Reportlinker.com

Reportlinker.com

March 11, 2008 10:01 ET

High Growth Reported for the US Drug Delivery Systems Market

LONDON, UNITED KINGDOM--(Marketwire - March 11, 2008) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue.

US Drug Delivery Systems Market

Demand to grow more than 10% annually through 2012

US demand for drug delivery systems is projected to expand more than ten percent annually to $132 billion in 2012. Growth opportunities for drug delivery systems extend into all therapeutic classes of pharmaceuticals and encompass a wide range of compounds and formulations. Central nervous system, respiratory and hormone and related agents will remain the top three applications based on the special formulating needs of medicines for conditions such as arthritis, multiple sclerosis, asthma, allergies and cancer. However, favorable growth opportunities will emerge for drug delivery systems in most other therapeutic classes due to safety and efficacy shortcomings in many conventional medicines.

Parenteral types to exhibit best growth opportunities

Oral drug delivery systems will remain the largest method used for drug delivery. Orally disintegrating tablets and transmucosal drugs will generate strong growth opportunities in the delivery of pain control and other critical care medication. Ease of administration advantages will promote the widening use of chewable tablet dosages for nutritional, respiratory and central nervous system agents, especially pediatric preparations. Better solubility and pharmacokinetic actions will lead to rapid growth both in the number and sales of oral nanoparticle drugs. Among pharmaceutical dosage formulations, parenteral preparations will provide the strongest growth opportunities for drug delivery systems. Precise targeting advantages in the treatment of cancer and other debilitating diseases will broaden demand for therapeutic monoclonal antibodies. Extended circulation and reduced toxicity benefits will expand the range of indications served by polymer- and liposome-encapsulated drugs, especially in the areas of cancer, neurological and anti-infective therapies. Ease of administration and infection prevention advantages will boost the market for parenteral drugs and solutions sold in prefilled syringes and premixed IV systems. An increasing incidence of chronic respiratory conditions, coupled with the need for safer and more effective therapies, will boost growth prospects for inhalation drug delivery systems. Based on widespread use in asthma therapy, dry powder inhaler formulations will continue to record the largest share of sales. However, metered dose drugs will see slightly faster gains in demand due to ongoing improvements in particle size and propellent safety. Lastly, transdermal patches will continue to broaden pharmaceutical applications as advances in administration modalities and design lead to new uses in pain control and cardiovascular medication.

Study coverage

It presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 by type and application. The study also considers US market environment factors, evaluates company market share and profiles 43 industry competitors.

Executive Summary

1 Executive Summary

Market Environment

General

Macroeconomic Trends

Demographic Patterns

Health Care Trends

Health Insurance

Medical Conditions

Acute Conditions

Chronic Conditions

National Health Expenditures

Medical Providers

Patient Activity

Pharmaceutical Market Overview

Regulation

Research & Development

Demand Patterns & Forecasts

Therapeutic Classes

Generic Competition

Ethical Pharmaceuticals

Over-the-Counter Pharmaceuticals

1 Macroeconomic Indicators

2 Population by Age Group

3 Acute Conditions by Type

4 Chronic Conditions by Type

5 National Health Expenditures by Type

6 Selected Medical Providers

7 Selected Patient Activity

8 Pharmaceutical Demand

by Therapeutic Class

9 Pharmaceutical Demand

by Commercial Status

10 Pharmaceutical Demand

by Dosage Formulation

11 Pharmaceutical Demand

by Regulatory Classification

DRUG DELIVERY MATERIALS

General

Sterile & Purified Water

Synthetic Polymers

Cellulose Derivatives

Minerals

Other Materials

Starch Compounds

Natural Gums

Sugars & Polyols

All Other Materials

1 Drug Delivery Material Demand by Type

Cht Drug Delivery System Material

Demand by Type

2 Sterile & Purified Water Demand

in Drug Delivery Systems

3 Synthetic Polymer Demand

in Drug Delivery Systems

4 Cellulose Derivative Demand

in Drug Delivery Systems

5 Mineral Demand in Drug Delivery Systems

6 Other Material Demand

in Drug Delivery Systems

DRUG DELIVERY SYSTEMS OVERVIEW

General

Types of Drug Delivery Systems

Technologies

Historical Demand Patterns

US Trade

International Markets

1 Drug Delivery System Demand by Type

Cht Drug Delivery System Demand by Type, 2007

2 Drug Delivery System Demand

Patterns, 1997-2007

3 US Trade in Drug Delivery Systems

4 World Drug Delivery System Demand

ORAL DRUG DELIVERY SYSTEMS

General

Sustained-Release Formulations

Tablet Formulations

Capsule Formulations

Other Formulations

Delayed-Release Formulations

Capsule Formulations

Tablet Formulations

Chewable Tablets

Orally Disintegrating Tablets

Nanoparticle Formulations

Transmucosal Formulations

1 Oral Drug Delivery System Demand by Type

Cht Oral Drug Delivery System

Demand by Type, 2007

2 Sustained-Release Pharmaceutical Demand

by Therapeutic Class & Formulation

3 Delayed-Release Pharmaceutical Demand

by Therapeutic Class & Formulation

4 Chewable Tablet Demand

by Therapeutic Class

5 Orally Disintegrating Tablet Demand

by Therapeutic Class

6 Nanoparticle-Based Oral Pharmaceutical

Demand by Therapeutic Class

7 Oral Transmucosal Pharmaceutical Demand

by Therapeutic Class

PARENTERAL DRUG

DELIVERY SYSTEMS

General

Therapeutic Monoclonal Antibodies

Anti-Cancer Agents

Central Nervous System Agents

Other

Prefilled Syringes

Injectors

Cartridges & Pens

Encapsulated Formulations

Polymer-Protected

Liposomes

Premixed IV Solutions

Bag/Vial Infusion Systems

Mini-Bags

Other

1 Parenteral Drug Delivery System

Demand by Type

Cht Parenteral Drug Delivery System

Demand by Type, 2007

2 Therapeutic Monoclonal Antibody

Demand by Therapeutic Class

3 Prefilled Syringe Demand

by Type & Therapeutic Class

4 Encapsulated Parenteral Pharmaceutical

Demand by Type & Therapeutic Class

5 Premixed IV Solution Demand

by Type & Therapeutic Class

INHALATION, IMPLANTABLE

& TRANSDERMAL DRUG

DELIVERY SYSTEMS

General

Inhalation Drug Delivery Systems

Dry Powder Formulations

Metered Dose Spray Formulations

Aerosol Formulations

Implantable Drug Delivery Systems

Drug-Eluting Stents

Drug Inserts

Brachytherapy Seeds

Transdermal Drug Delivery Systems

Central Nervous System Agents

Hormones & Related Agents

Cardiovascular Agents

Other

1 Inhalation, Implantable & Transdermal Drug

Delivery System Demand by Type

2 Inhalation Drug Delivery System Demand

by Type & Therapeutic Class

Cht Inhalation Drug Delivery System

Demand by Type, 2007

3 Dry Powder Inhalation

Pharmaceutical Demand

4 Metered Dose Pharmaceutical Demand

5 Aerosol Pharmaceutical Demand

6 Implantable Drug Delivery System Demand

by Type & Therapeutic Class

Cht Implantable Drug Delivery System

Demand by Type, 2007

7 Drug-Eluting Stent Demand

8 Insertable Pharmaceutical Demand

9 Brachytherapy Demand

10 Transdermal Drug Delivery System Demand

by Therapeutic Class

Cht Transdermal Drug Delivery System Demand

by Therapeutic Class, 2007

APPLICA TIONS

General

Central Nervous System Agents

Respiratory Agents

Hormones & Related Agents

Anti-Cancer Agents

Other

Gastrointestinal Agents

Cardiovascular Agents

Anti-Infective Agents

Nutritional Agents

Biologicals

Genito-Urinary Agents

Other

Anti-Transplant Rejection Agents

Dermatological Agents

All Other Pharmaceuticals

1 Drug Delivery System Demand

by Therapeutic Class

Cht Drug Delivery System Demand

by Therapeutic Class, 2007

2 Central Nervous System Drug Delivery

System Demand by Type

3 Respiratory Drug Delivery System

Demand by Type

4 Hormones & Related Drug Delivery System

Demand by Type & Compound

5 Gastrointestinal Drug Delivery System

Demand by Type

6 Cardiovascular Drug Delivery System

Demand by Type

7 Anti-Infective Drug Delivery System

Demand by Type

8 Nutritional Drug Delivery System

Demand by Type

9 Biological Drug Delivery System

Demand by Type

10 Genito-Urinary Drug Delivery System

Demand by Type

11 Drug Delivery System Demand

in Other Therapeutic Classes

INDUSTRY STRUCTURE

General

Market Share

Competitive Strategies

Mergers & Acquisitions

Licensing & Collaborative Agreements

Research & Development Activities

Marketing & Distribution

Manufacturing

1 Drug Delivery System Sales

by Company, 2007

Cht Drug Delivery Systems,

Market Share by Company, 2007

2 Selected Acquisitions & Divestitures

3 Selected Cooperative Agreements

Company Profiles

To order this report:

US Drug Delivery Systems Market

More market research reports?

Go to http://www.reportlinker.com

Contact Information